The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors

por Dalakas, Marinos C., Spaeth, Peter J.
Publicado 2021

Complement in neurological disorders and emerging complement-targeted therapeutics

por Dalakas, Marinos C., Alexopoulos, Harry, Spaeth, Peter J.
Publicado 2020

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

por Maurer, Marcus, Magerl, Markus, Betschel, Stephen, Aberer, Werner, Ansotegui, Ignacio J., Aygören-Pürsün, Emel, Banerji, Aleena, Bara, Noémi-Anna, Boccon-Gibod, Isabelle, Bork, Konrad, Bouillet, Laurence, Boysen, Henrik Balle, Brodszki, Nicholas, Busse, Paula J., Bygum, Anette, Caballero, Teresa, Cancian, Mauro, Castaldo, Anthony J., Cohn, Danny M., Csuka, Dorottya, Farkas, Henriette, Gompels, Mark, Gower, Richard, Grumach, Anete S., Guidos-Fogelbach, Guillermo, Hide, Michihiro, Kang, Hye-Ryun, Kaplan, Allen P., Katelaris, Constance H., Kiani-Alikhan, Sorena, Lei, Wei-Te, Lockey, Richard F., Longhurst, Hilary, Lumry, William, MacGinnitie, Andrew, Malbran, Alejandro, Martinez Saguer, Inmaculada, Matta Campos, Juan José, Nast, Alexander, Nguyen, Dinh, Nieto-Martinez, Sandra A., Pawankar, Ruby, Peter, Jonathan, Porebski, Grzegorz, Prior, Nieves, Reshef, Avner, Riedl, Marc, Ritchie, Bruce, Sheikh, Farrukh Rafique, Smith, William B., Spaeth, Peter J., Stobiecki, Marcin, Toubi, Elias, Varga, Lilian Agnes, Weller, Karsten, Zanichelli, Andrea, Zhi, Yuxiang, Zuraw, Bruce, Craig, Timothy
Publicado 2022